Advertisement: TTP Killer 50
17 April, 2019 - 12:14 By Kate Sweeney

Sosei Heptares

Sosei Heptares is an international biopharmaceutical group focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR® technology and Structure-Based Drug Design platform capabilities.

It is advancing a broad pipeline of partnered and in-house drug candidates in multiple therapeutic areas including neurology, immuno-oncology, gastroenterology, inflammation and rare/specialty diseases.

Newsletter Subscription

Stay informed of the latest news and features